StockComparison Logo
vs

GSK vs SPY

Comparison between GSK Plc (GSK, Company) and SPDR S&P 500 ETF Trust (SPY, ETF).

5-Year PerformanceSPY has outperformed GSK, delivering a return of +13.3% compared to +5.4%

GSK vs SPY - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap / Net Assets
GSK
$103B
Winner
SPY
$652B
Expense Ratio
GSK
N/A
SPY
0.09%
Max Drawdown
GSK
64.03%
Winner
SPY
56.47%
Sharpe Ratio
GSK
1.27
Winner
SPY
2.07
5Y Beta
Winner
GSK
0.25
SPY
1.00
Industry
GSK
Drug Manufacturers - General
SPY
N/A
P/E Ratio
Winner
GSK
11.89
SPY
28.24
Forward P/E
Winner
GSK
9.85
SPY
21.85
PEG Ratio
GSK
0.10
SPY
N/A
Dividend Yield
GSK
3.57%
SPY
N/A
5Y Dividends CAGR
GSK
-8.44%
Winner
SPY
5.43%
5Y EPS CAGR
GSK
4.65%
Winner
SPY
25.79%
Debt to Equity
GSK
106.74%
Winner
SPY
22.35%
Free Cash Flow Yield
GSK
8.17%
SPY
N/A
P/S Ratio
Winner
GSK
3.10
SPY
3.55
P/B Ratio
Winner
GSK
4.19
SPY
5.29

GSK vs SPY - Historical Returns

Returns include dividend reinvestment.

1M
GSK
-12.15%
Winner
SPY
+9.11%
3M
GSK
-13.89%
Winner
SPY
+6.59%
6M
GSK
+9.93%
Winner
SPY
+10.56%
1Y
Winner
GSK
+42.14%
SPY
+32.04%
5Y(CAGR)
GSK
+5.35%
Winner
SPY
+13.35%
10Y(CAGR)
GSK
+4.24%
Winner
SPY
+15.49%
Max(CAGR)
GSK
+3.02%
Winner
SPY
+8.50%

GSK vs SPY - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKSPY
2026+2.38%+8.27%
2025+50.62%+18.00%
2024-6.27%+25.59%
2023+9.25%+26.72%
2022-32.73%-18.64%
2021+23.62%+30.52%
2020-17.52%+17.28%
2019+30.36%+31.09%
2018+9.29%-5.24%
2017-3.80%+20.78%
2016+1.52%+13.59%
2015+0.48%+1.31%
2014-14.73%+14.56%
2013+26.97%+29.00%
2012-0.75%+14.17%
2011+22.51%+0.85%
2010-3.72%+13.14%
2009+20.27%+22.67%
2008-21.93%-36.25%
2007-2.77%+5.32%
2006+6.93%+13.85%
2005+9.96%+5.32%
2004+5.08%+10.75%
2003+25.04%+24.18%
2002-22.83%-22.42%
2001-9.58%-10.13%
2000+5.67%-8.84%
1999-5.78%+8.61%

GSK vs SPY Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for SPY was -55.20%, occurring on Mar 9, 2009. Recovery took 1224 trading sessions.

The current GSK drawdown is -16.95%.

RankGSKSPY
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-55.20%
Oct 9, 2007 - Aug 16, 2012
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-47.50%
Mar 24, 2000 - Oct 26, 2006
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-33.70%
Feb 19, 2020 - Aug 10, 2020
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-24.50%
Jan 3, 2022 - Dec 13, 2023
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-19.34%
Sep 20, 2018 - Apr 12, 2019
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-18.76%
Feb 19, 2025 - Jun 26, 2025
#7-16.98%
Feb 18, 2026 - May 5, 2026
-13.02%
Jul 20, 2015 - Apr 18, 2016
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-10.10%
Jan 26, 2018 - Aug 6, 2018
#9-10.52%
May 16, 2006 - Feb 13, 2007
-9.44%
Sep 2, 2020 - Nov 11, 2020
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-9.30%
Jan 19, 2000 - Mar 17, 2000
#11-8.45%
May 28, 2013 - Nov 1, 2013
-9.05%
Jul 19, 2007 - Oct 5, 2007
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-8.88%
Jan 27, 2026 - Apr 14, 2026
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-8.41%
Jul 16, 2024 - Sep 19, 2024
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-7.35%
Sep 14, 2012 - Jan 2, 2013
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-7.27%
Sep 18, 2014 - Oct 31, 2014

Correlation

Correlation between GSK and SPY is 0.79 which considered as a strong positive correlation - the stocks tend to move together.

0.79
-101

Dividend Comparison (1999 - 2026)

GSK vs SPY dividend yield comparison.

YearGSKSPY
20260.96%0.24%
20253.42%1.07%
20244.60%1.21%
20233.75%1.40%
20225.47%1.65%
20214.99%1.20%
20205.59%1.52%
20194.35%1.75%
20185.65%2.04%
20175.83%1.80%
20166.86%2.03%
20155.93%2.06%
20146.20%1.87%
20134.51%1.81%
20125.70%2.18%
20114.83%2.05%
20105.10%1.80%
20094.39%1.95%
20085.74%3.02%
20074.09%1.85%
20063.29%1.73%
20053.03%1.73%
20043.38%1.82%
20032.77%1.47%
20023.10%1.70%
20011.54%1.25%
20004.57%1.15%
19990.00%0.24%

Select Stocks to Compare

Popular: GSK vs SPY